home / stock / innpf / innpf news

INNPF News and Press, Innovative Properties Inc From 04/11/22

Stock Information
Company Name: Innovative Properties Inc
Stock Symbol: INNPF
Market: OTC
Website: innocanpharma.com
Menu
INNPF INNPF Quote INNPF Short INNPF News INNPF Articles INNPF Message Board
Get INNPF Alerts

News, Short Squeeze, Breakout and More Instantly...
INNPF - Innocan Pharma's Case Report Accepted to the 25M Readers of Frontiers Veterinary Scientific Journal

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to report the "accepted for publication" of a Case Report Article describing subcutaneously injected liposomal ca...
INNPF - Innocan Pharma Reports a Successful FDA-Required Characterization of Highly CBD-Loaded Liposome Platform

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 28, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to report the successful completion of Innocan's CBD Liposome drug-product physico-chemical characterization. Phy...

INNPF - Innocan Pharma Reports a Positive Result from the Use of Its CBD LPT on a Dog Suffering from Osteoarthritis

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 8, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the " Company " or " Innocan "), is pleased to announce that Innocan's CBD LPT injection provided as a treatment to a dog suffering from osteoarthritis of...

INNPF - Former Beckman Coulter Dr. Eyal Kalo to join Innocan Pharma's Expanding R&D Team

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 4, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the appointment of Dr. Eyal Kalo as Research and Development Project Manager. In this new role Dr. Eyal...
INNPF - Sony Ex-VP Dr. Kenji Kitatani to Join Innocan Pharma's Advisory Committee

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - February 7, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the addition of Dr. Kenji Kitatani, a leading global media business expert, and former Executive Off...

INNPF - Innocan Pharma Announces Important Updates Regarding its LPT Platform Project and Commercialization Paths

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 20, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the " Company " or " Innocan "), is pleased to provide an update on its research into CBD loaded liposomes using Innocan's LPT platform. Innocan's core...

INNPF - Cannabis Industry Investor Conference: Company Executives Present January 19th & 20th

NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invi...
INNPF - Innocan Pharma Announces the Inauguration of Its Drug Development Lab at Biohouse in the Hadassah Medical Center in Jerusalem

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the " Company " or " Innocan ") is pleased to announce that it has inaugurated its first and new drug research and development lab at Biohouse Labs at ...

INNPF - Innocan Pharma to Expand its LPT Platform to the Veterinary Field

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 13, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the " Company " or " Innocan "), is pleased to announce a second amendment (the " Amendment ") to the research and license agreement with Yissum Resear...

INNPF - Innocan Announces the Execution of a Research & License Agreement with Ramot, the Technology Transfer Company of the Tel Aviv University for Cannabinoids Loaded Exosome Delivery Platform (CLX)

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - December 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the " Company " or " Innocan "), is pleased to announce today that after the early substantial positive results of its CBD Loaded Exosome Platform (CLX...
Previous 10 Next 10